Optiscan Imaging Limited (ASX:OIL)
0.1150
-0.0050 (-4.17%)
Jun 24, 2025, 11:15 AM AEST
Optiscan Imaging Company Description
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States.
It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research.
The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery.
Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Optiscan Imaging Limited
Country | Australia |
Founded | 1994 |
Industry | Scientific & Technical Instruments |
Sector | Technology |
Employees | 9 |
CEO | Camile Farah |
Contact Details
Address: 16 Miles Street Mulgrave, 3170 Australia | |
Phone | 61 3 9538 3333 |
Website | optiscan.com |
Stock Details
Ticker Symbol | OIL |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU000000OIL4 |
SIC Code | 3827 |
Key Executives
Name | Position |
---|---|
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D. | Chief Executive Officer, MD, President and Executive Director |
Darius Ooi | Chief Financial Officer |
Dr. Sanchitha Fernando | Chief Technology Officer |
Kaylene Dawson | General Counsel |
Belinda Williamson | Chief Commercial Officer |
Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC | Company Secretary |